<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ahrazoglu T</submitter><funding>Deutsche Forschungsgemeinschaft</funding><funding>Susanne-Bunnenberg-Stiftung at the Düsseldorf Heart Center</funding><pagination>1251</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11506830</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(10)</volume><pubmed_abstract>Human monocytes can be subdivided into phenotypically and functionally different classical, intermediate and non-classical monocytes according to the cell surface expression of CD14 and CD16. A precise identification and characterisation of monocyte subsets is necessary to unravel their role in inflammatory diseases. Here, we compared three different flow cytometric strategies (A-C) and found that strategy C, which included staining against CD11b, HLA-DR, CD14 and CD16, followed by several gating steps, most reliably identified monocyte subtypes in blood samples from healthy volunteers and from patients with stable coronary heart disease (CHD) or ST-elevation myocardial infarction (STEMI). Additionally, we established a fixation and permeabilisation protocol to enable the analysis of intracellular markers. We investigated the phagocytosis of lipid nanoparticles, the uptake of 2-NBD-glucose and the intracellular levels of CD74 and HLA-DM. This revealed that classical and intermediate monocytes from patients with STEMI showed the highest uptake of 2-NBD-glucose, whereas classical and intermediate monocytes from patients with CHD took up the largest amounts of lipid nanoparticles. Interestingly, intermediate monocytes had the highest expression level of HLA-DM. Taken together, we present a robust flow cytometric approach for the identification and functional characterisation of monocyte subtypes in healthy humans and patients with diseases.</pubmed_abstract><journal>Biomolecules</journal><pubmed_title>Design of a Robust Flow Cytometric Approach for Phenotypical and Functional Analysis of Human Monocyte Subsets in Health and Disease.</pubmed_title><pmcid>PMC11506830</pmcid><funding_grant_id>397484323</funding_grant_id><funding_grant_id>none</funding_grant_id><funding_grant_id>236177352</funding_grant_id><pubmed_authors>Temme S</pubmed_authors><pubmed_authors>Nienhaus FT</pubmed_authors><pubmed_authors>Kluczny JI</pubmed_authors><pubmed_authors>Bonner F</pubmed_authors><pubmed_authors>Irschfeld LM</pubmed_authors><pubmed_authors>Ahrazoglu T</pubmed_authors><pubmed_authors>Kleimann P</pubmed_authors><pubmed_authors>Gerdes N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Design of a Robust Flow Cytometric Approach for Phenotypical and Functional Analysis of Human Monocyte Subsets in Health and Disease.</name><description>Human monocytes can be subdivided into phenotypically and functionally different classical, intermediate and non-classical monocytes according to the cell surface expression of CD14 and CD16. A precise identification and characterisation of monocyte subsets is necessary to unravel their role in inflammatory diseases. Here, we compared three different flow cytometric strategies (A-C) and found that strategy C, which included staining against CD11b, HLA-DR, CD14 and CD16, followed by several gating steps, most reliably identified monocyte subtypes in blood samples from healthy volunteers and from patients with stable coronary heart disease (CHD) or ST-elevation myocardial infarction (STEMI). Additionally, we established a fixation and permeabilisation protocol to enable the analysis of intracellular markers. We investigated the phagocytosis of lipid nanoparticles, the uptake of 2-NBD-glucose and the intracellular levels of CD74 and HLA-DM. This revealed that classical and intermediate monocytes from patients with STEMI showed the highest uptake of 2-NBD-glucose, whereas classical and intermediate monocytes from patients with CHD took up the largest amounts of lipid nanoparticles. Interestingly, intermediate monocytes had the highest expression level of HLA-DM. Taken together, we present a robust flow cytometric approach for the identification and functional characterisation of monocyte subtypes in healthy humans and patients with diseases.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2025-04-04T03:04:07.732Z</modification><creation>2025-04-04T03:04:07.732Z</creation></dates><accession>S-EPMC11506830</accession><cross_references><pubmed>39456184</pubmed><doi>10.3390/biom14101251</doi></cross_references></HashMap>